InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Use this INM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INM SEC filings page. Lician reads the product cache first so this HTML stays unique to InMed Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full INM income, balance, and cash tables.